Rift Valley fever (RVF) is an arthropod-borne zoonotic disease responsible for severe outbreaks in livestock and humans with concomitant economic losses in many countries in sub-Saharan Africa. The study, therefore, investigated the seroprevalence of the Rift Valley fever virus (RVFV) among wild and domestic animals. Blood samples were collected between 2013 and 2015 from 106 wild animals, 300 cattle (Bos indicus), and 200 horses (Equus caballus), respectively, in Yankari Game Reserve (YGR) and Sumu Wildlife Park (SWP) in Bauchi state, Nigeria. Harvested sera from blood were evaluated for the presence of anti-RVFV IgM/IgG antibodies. The overall seroprevalence in cattle was 11.3% (
p
= 0.677; 95% CI: 0.624–0.730) and in wildlife was 8.5% (
p
= 0.006; 95% CI: 0.00–0.60). The diversity of wildlife species sampled indicated seropositivity of 36.0% in waterbuck (Kobus ellipsiprymus), 25.0% in elephant (Loxodonta africana), 12.5% in eland (Taurotragus oryx), and 8.3% in wildebeest (Connochaetes taurinus). Whereas, samples from zebra (Equus quagga crawshayi), kudu (Tragelaphus strepsiceros), and hartebeest (Alcelaphus buselaphus caama) did not show detectable antibodies to RVFV, and seroprevalence in female (15.0%) wildlife species was higher than in males (4.5%) (
p
= 0.061). Classification of cattle into breed and sex showed no significant difference in seropositivity. Seropositivity of 12.0% was observed in White Fulani, 12.1% in Red Bororo, and 7.8% in Sokoto Gudali breeds of cattle (
p
= 0.677). Whereas, seropositivity of 13.6% was observed in females and 6.4% observed in males (
p
= 0.068). This study indicated the presence of antibodies to RVFV among some wild animals and cattle in the absence of a reported outbreak in the study area. The circulation of RVFV in the study area may pose a significant health risk to livestock, wildlife, and humans. Therefore, surveillance for RVFV should be intensified targeting mosquito vectors and humans in Bauchi state, Nigeria.
